ArticleBritish journal of pharmacology2013

Sorafenib and its derivative SC-49 sensitize hepatocellular carcinoma cells to CS-1008, a humanized anti-TNFRSF10B (DR5) antibody.

Kuen-Feng Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.